Phase II Study to Investigate the Treatment of Patients With NSCLC Stage IIIB and IV Without the Option of Surgery With a Combination of Cisplatin, Docetaxel and Bevacizumab
Phase of Trial: Phase II
Latest Information Update: 29 Aug 2013
At a glance
- Drugs Bevacizumab; Cisplatin; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 04 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Jun 2011 Integrated EudraCT record.
- 10 Jun 2011 New trial record